337
Views
17
CrossRef citations to date
0
Altmetric
Reviews

New therapeutic strategies under development to halt the progression of renal failure

, , , , & , MD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Viviana Lacava, Vincenzo Pellicanò, Carmen Ferrajolo, Valeria Cernaro, Luca Visconti, Giovanni Conti, Michele Buemi & Domenico Santoro. (2017) Novel avenues for treating diabetic nephropathy: new investigational drugs. Expert Opinion on Investigational Drugs 26:4, pages 445-462.
Read now
Valeria Cernaro, Domenico Santoro, Antonio Lacquaniti, Giuseppe Costantino, Luca Visconti, Antoine Buemi & Michele Buemi. (2016) Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. International Journal of Nephrology and Renovascular Disease 9, pages 11-19.
Read now
Domenico Santoro, Vincenzo Pellicanò, Luca Visconti, Gianluca Trifirò, Michele Buemi & Valeria Cernaro. (2015) An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease. Expert Opinion on Investigational Drugs 24:9, pages 1199-1218.
Read now
Francesco Paolo Schena. (2014) Biomarkers and personalized therapy in chronic kidney diseases. Expert Opinion on Investigational Drugs 23:8, pages 1051-1054.
Read now

Articles from other publishers (13)

Valeria Cernaro, Saverio Loddo, Vincenzo Macaione, Valentina Teresa Ferlazzo, Rosalia Maria Cigala, Francesco Crea, Concetta De Stefano, Antonina Rita Rosalia Genovese, Guido Gembillo, Davide Bolignano, Domenico Santoro, Roberto Vita, Michele Buemi & Salvatore Benvenga. (2020) RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus. International Urology and Nephrology 52:6, pages 1125-1133.
Crossref
Emilia Bigaeva, Elisabeth G. D. Stribos, Henricus A. M. Mutsaers, Bram Piersma, Anna M. Leliveld, Igle J. de Jong, Ruud A. Bank, Marc A. Seelen, Harry van Goor, Lutz Wollin, Peter Olinga & Miriam Boersema. (2020) Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis. American Journal of Physiology-Renal Physiology 318:1, pages F117-F134.
Crossref
Valeria Cernaro, Giovanni Tripepi, Luca Visconti, Antonio Lacquaniti, Gaetano Montalto, Adolfo Romeo, Domenica Cimadoro, Giuseppe Costantino, Francesco Torre, Domenico Santoro & Michele Buemi. (2018) Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis. Therapeutic Apheresis and Dialysis 22:5, pages 457-468.
Crossref
Valeria Cernaro, Maria A Medici, Federica Bianco, Domenico Santoro, Antonio Lacquaniti, Adolfo Romeo, Silvia Lucisano, Antoine Buemi & Michele Buemi. (2017) Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study. Clinical and Experimental Pharmacology and Physiology 44:10, pages 1069-1071.
Crossref
Vincenzo Bellizzi, Giuseppe Conte, Silvio Borrelli, Adamasco Cupisti, Luca De Nicola, Biagio R. Di Iorio, Gianfranca Cabiddu, Marcora Mandreoli, Ernesto Paoletti, Giorgina B. Piccoli, Giuseppe Quintaliani, Maura Ravera, Domenico Santoro, Serena Torraca & Roberto Minutolo. (2016) Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology. Journal of Nephrology 30:2, pages 159-170.
Crossref
Luca Visconti, Salvatore Benvenga, Antonio Lacquaniti, Valeria Cernaro, Annamaria Bruzzese, Giovanni Conti, Michele Buemi & Domenico Santoro. (2016) Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease. Journal of Clinical & Translational Endocrinology 6, pages 8-14.
Crossref
Elisabeth G.D. Stribos, Jan-Luuk Hillebrands, Peter Olinga & Henricus A.M. Mutsaers. (2016) Renal fibrosis in precision-cut kidney slices. European Journal of Pharmacology 790, pages 57-61.
Crossref
Jehrod Brenneman, Jon Hill & Steve Pullen. (2016) Emerging therapeutics for the treatment of diabetic nephropathy. Bioorganic & Medicinal Chemistry Letters 26:18, pages 4394-4402.
Crossref
Domenico Santoro, Vincenzo Pellicanò, Luca Visconti, Viviana Lacava, CarloAlberto Ricciardi, Antonio Lacquaniti, Valeria Cernaro & Michele Buemi. (2018) New options for the management of polycystic kidney disease. Giornale di Tecniche Nefrologiche e Dialitiche 28:2, pages 143-152.
Crossref
Elisabeth G.D. Stribos, Theerut Luangmonkong, Anna M. Leliveld, Igle J. de Jong, Willem J. van Son, Jan-Luuk Hillebrands, Marc A. Seelen, Harry van Goor, Peter Olinga & Henricus A.M. Mutsaers. (2016) Precision-cut human kidney slices as a model to elucidate the process of renal fibrosis. Translational Research 170, pages 8-16.e1.
Crossref
Anne Davidson. (2015) What is damaging the kidney in lupus nephritis?. Nature Reviews Rheumatology 12:3, pages 143-153.
Crossref
P. IyngkaranM. Thomas. (2015) Bedside–to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients who do Not Meet Trial Enrollment Criteria. Clinical Medicine Insights: Cardiology 9s1, pages CMC.S18737.
Crossref
Anna Pleskačová, Vendula Bartáková, Lukáš Pácal, Katarína Kuricová, Jana Bělobrádková, Josef Tomandl & Kateřina Kaňková. (2015) Vitamin D Status in Women with Gestational Diabetes Mellitus during Pregnancy and Postpartum. BioMed Research International 2015, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.